VCEL Vericel Corp

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company. The Company operates in one reportable segment: the research, manufacture, and distribution of patient-specific, used in the treatment of specific diseases.

$37.26  -0.05 (-0.13%)
As of 11/30/2021 15:59:56 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  08/06/2001
Outstanding shares:  46,815,257
Average volume:  382,283
Market cap:   $1,793,492,496
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    92346J108
ISIN:        US92346J1088
Sedol:      BSBMN89

---

Valuation   (See tab for details)

---

PE ratio:   8,162.33
PB ratio:   11.13
PS ratio:   11.66
Return on equity:   0.14%
Net income %:   0.14%